MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction

Phillip H Kuo, Ali Abu-Alfa, Richard Bucala, Jason Griffith, Kacie Carlson, Michael Girardi, Jeffrey Weinreb, Shawn Cowper

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.

Original languageEnglish (US)
Pages (from-to)22-33
Number of pages12
JournalApplied Radiology
Volume38
Issue number4
StatePublished - Apr 2009

Fingerprint

Nephrogenic Fibrosing Dermopathy
Risk Reduction Behavior
Magnetic Resonance Imaging
Confusion
Gadolinium
Kidney Diseases
Radiology
Contrast Media

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Kuo, P. H., Abu-Alfa, A., Bucala, R., Griffith, J., Carlson, K., Girardi, M., ... Cowper, S. (2009). MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction. Applied Radiology, 38(4), 22-33.

MRI in the era of nephrogenic systemic fibrosis : Review, controversies and suggestions for risk reduction. / Kuo, Phillip H; Abu-Alfa, Ali; Bucala, Richard; Griffith, Jason; Carlson, Kacie; Girardi, Michael; Weinreb, Jeffrey; Cowper, Shawn.

In: Applied Radiology, Vol. 38, No. 4, 04.2009, p. 22-33.

Research output: Contribution to journalArticle

Kuo, PH, Abu-Alfa, A, Bucala, R, Griffith, J, Carlson, K, Girardi, M, Weinreb, J & Cowper, S 2009, 'MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction', Applied Radiology, vol. 38, no. 4, pp. 22-33.
Kuo PH, Abu-Alfa A, Bucala R, Griffith J, Carlson K, Girardi M et al. MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction. Applied Radiology. 2009 Apr;38(4):22-33.
Kuo, Phillip H ; Abu-Alfa, Ali ; Bucala, Richard ; Griffith, Jason ; Carlson, Kacie ; Girardi, Michael ; Weinreb, Jeffrey ; Cowper, Shawn. / MRI in the era of nephrogenic systemic fibrosis : Review, controversies and suggestions for risk reduction. In: Applied Radiology. 2009 ; Vol. 38, No. 4. pp. 22-33.
@article{c50261523dc5400aa5467c70cc633286,
title = "MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction",
abstract = "In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.",
author = "Kuo, {Phillip H} and Ali Abu-Alfa and Richard Bucala and Jason Griffith and Kacie Carlson and Michael Girardi and Jeffrey Weinreb and Shawn Cowper",
year = "2009",
month = "4",
language = "English (US)",
volume = "38",
pages = "22--33",
journal = "Applied Radiology",
issn = "0160-9963",
publisher = "Anderson Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - MRI in the era of nephrogenic systemic fibrosis

T2 - Review, controversies and suggestions for risk reduction

AU - Kuo, Phillip H

AU - Abu-Alfa, Ali

AU - Bucala, Richard

AU - Griffith, Jason

AU - Carlson, Kacie

AU - Girardi, Michael

AU - Weinreb, Jeffrey

AU - Cowper, Shawn

PY - 2009/4

Y1 - 2009/4

N2 - In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.

AB - In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.

UR - http://www.scopus.com/inward/record.url?scp=65249160161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249160161&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:65249160161

VL - 38

SP - 22

EP - 33

JO - Applied Radiology

JF - Applied Radiology

SN - 0160-9963

IS - 4

ER -